Us Fda Approves Zoetis Solensia To Control Osteoarthritis Pain In Cats
Zoetis Inc., A Leading Animal Health Company, Announced That The Us Food And Drug Administration (Fda) Has Approved Solensia To Control The Pain Of Osteoarthritis (Oa) In Cats, Helping Improve Their Mobility, Comfort And Overall Well-Being. As A Once-Monthly Injection Administered In The Veterinary Clinic, Solensia Keeps Oa Pain From Disrupting The Unique Bond Cats Share With Their Humans.Feline Oa, A Highly Prevalent Condition With Nearly 40% Of All Cats Showing Signs Of Oa Pain, Occurs When The Protective Tissue In The Joints (Cartilage) Is Worn Down, Causing Bones To Rub Together. This Makes Moving Harder And Causes Severe Pain. Without Treatment, Oa Pain Can Worsen Over Time And Seriously Affect A Cat
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!